Catharine A. Hellingman

Smad Signaling Determines Chondrogenic Differentiation of Bone-Marrow-Derived Mesenchymal Stem Cells: Inhibition of Smad1/5/8P Prevents Terminal Differentiation and Calcification

Catharine A. Hellingman, E.N. Blaney Davidson, Wendy Koevoet et al. · Tissue Engineering Part A · 2010 · 181 citations

Life Sciences, Cell Biology, Developmental Biology +17

Chondrogenic Priming of Human Bone Marrow Stromal Cells: A Better Route to Bone Repair?

Eric Farrell, Olav P. van der Jagt, Wendy Koevoet et al. · Tissue Engineering Part C Methods · 2008 · 132 citations

Medicine, Cell Biology, Orthopaedic Surgery +17

Risk of Rebleeding After Treatment of Acute Hydrocephalus in Patients With Aneurysmal Subarachnoid Hemorrhage

Catharine A. Hellingman, Walter M. van den Bergh, I. Beijer et al. · Stroke · 2006 · 105 citations · Full text

Medicine, Neurosurgery, Surgery +15

Fibroblast Growth Factor Receptors in <i>In Vitro</i> and <i>In Vivo</i> Chondrogenesis: Relating Tissue Engineering Using Adult Mesenchymal Stem Cells to Embryonic Development

Catharine A. Hellingman, Wendy Koevoet, Nicole Kops et al. · Tissue Engineering Part A · 2009 · 85 citations

Life Sciences, Cell Biology, Developmental Biology +16

Effects of transforming growth factor-β subtypes on in vitro cartilage production and mineralization of human bone marrow stromal-derived mesenchymal stem cells

F. L. J. Cals, Catharine A. Hellingman, W. Koevoet et al. · Journal of Tissue Engineering and Regenerative Medicine · 2011 · 72 citations

Engineering, Orthopaedic Surgery, Regenerative Medicine +8